Meyka Pro banner
Catalent, Inc.

Catalent, Inc. (CTLT) Stock Overview

Explore Catalent, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CTLTNYSE
HealthcareDrug Manufacturers - Specialty & Generic
$63.48
$0.00(0.00%)
U.S. Market is Open · 13:55

Catalent, Inc. (CTLT)

Meyka AI Score

Z

Key Financials

Market Cap11.5B
P/E Ratio-11.02
EPS (TTM)$-2.28
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$1.74

CTLT Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Catalent, Inc. (NYSE: CTLT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Catalent, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CTLT on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $1.74 for the NYSE listing.

Key metrics behind Catalent, Inc.'s NYSE-traded stock include a P/E ratio of -11.02 and a market capitalization of 11.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CTLT on the NYSE.

Price Performance (NYSE: CTLT)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
5.31%
6-Month Change
9.73%
Year-to-Date (YTD) Change
N/A
1-Year Change
28.45%
3-Year Change
-38.92%
5-Year Change
3.27%
All-Time (Max) Change
217.56%

Contact Information

732 537 6200
14 Schoolhouse Road, Somerset, NJ, 08873

Company Facts

170,000 Employees
IPO DateJul 31, 2014
CountryUS

Frequently Asked Questions